Increased expression of microRNA-9 predicts an unfavorable prognosis in human glioma

Molecular and Cellular Biochemistry

Volumn 384, Issue 1-2, 2013, Pages 263-268

  Wu, Zhenyu ^a   Wang, Liang ^b   Li, Gang ^b   Liu, Hui ^b   Fan, Feiyan ^b   Li, Zhaobo ^b   Li, Yunqing ^a   Gao, Guodong ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Glioma; microRNA 9; Prognosis; Real time quantitative RT PCR

Indexed keywords

MICRORNA 9;

ADJUVANT CHEMORADIOTHERAPY; ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN BIOPSY; BRAIN TISSUE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CHILD; CONTROLLED STUDY; FEMALE; GLIOMA; HUMAN; HUMAN TISSUE; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; TUMOR GROWTH;

ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; CHILD; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS; SURVIVAL; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; YOUNG ADULT;

EID: 84889030815     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1805-5     Document Type: Article

References (26)

1. Rousseau A, Mokhtari K, Duyckaerts C (2008) The 2007 WHO classification of tumors of the central nervous system - what has changed? Curr Opin Neurol 21:720-727
2. Chu SH, Ma YB, Feng DF, Zhang H, Zhu ZA, Li ZQ, Jiang PC (2012) Correlation of low SLC22A18 expression with poor prognosis in patients with glioma. J Clin Neurosci 19:95-98
3. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97-109
4. Zhang X, Yang H, Gong B, Jiang C, Yang L (2012) Combined gene expression and protein interaction analysis of dynamic modularity in glioma prognosis. J Neurooncol 107:281-288
5. Curran WJ Jr, Scott CB (1996) Radiosurgery for glioma patients: hope or hype? Int J Radiat Oncol Biol Phys 36:1279-1280
6. Esteller M (2011) Non coding RNAs in human disease. Nat Rev Genet 2011:861-874
7. van Kouwenhove M, Kedde M, Agami R (2011) microRNA regulation by RNA binding proteins and its implications for cancer. Nat Rev Cancer 11:644-656
8. Saal S, Harvey SJ (2009) microRNAs and the kidney: coming of age. Curr Opin Nephrol Hypertens 18:317-323
9. Rao SA, Santosh V, Somasundaram K (2010) Genome-wide expression profiling identifies deregulated miRNAs in malignant astrocytoma. Mod Pathol 23:1404-1417
10. Tang H, Yao L, Tao X, Yu Y, Chen M, Zhang R, Xu C (2013) miR-9 functions as a tumor suppressor in ovarian serous carcinoma by targeting TLN1. Int J Mol Med. doi: 10.3892/ijmm.2013.1400
11. Sun Z, Han Q, Zhou N, Wang S, Lu S, Bai C, Zhao RC (2013) microRNA-9 enhances migration and invasion through KLF17 in hepatocellular carcinoma. Mol Oncol 7:884-894
12. Wang J, Zhao H, Tang D, Wu J, Yao G, Zhang Q (2013) Overexpressions of microRNA-9 and microRNA-200c in human breast cancers are associated with lymph node metastasis. Cancer Biother Radiopharm. (in press)
13. Saito Y, Saito H (2012) microRNAs in cancers and neurodegenerative disorders. Front Genet 3:194
14. Nass D, Rosenwald S, Meiri E, Gilad S, Tabibian-Keissar H, Schlosberg A, Kuker H, Sion-Vardy N, Tobar A, Kharenko O, Sitbon E, Lithwick Yanai G, Elyakim E, Cholakh H, Gibori H, Spector Y, Bentwich Z, Barshack I, Rosenfeld N (2009) MiR-92b and miR-9/9* are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumors. Brain Pathol 19:375-383
15. Krell J, Frampton AE, Jacob J, Pellegrino L, Roca-Alonso L, Zeloof D, Alifrangis C, Lewis JS, Jiao LR, Stebbing J, Castellano L (2012) The clinico-pathologic role of microRNAs miR-9 and miR-151-5p in breast cancer metastasis. Mol Diagn Ther 16:167-172
16. Zhu L, Chen H, Zhou D, Li D, Bai R, Zheng S, Ge W (2012) microRNA-9 up-regulation is involved in colorectal cancer metastasis via promoting cell motility. Med Oncol 29:1037-1043
17. Leucci E, Zriwil A, Gregersen LH, Jensen KT, Obad S, Bellan C, Leoncini L, Kauppinen S, Lund AH (2012) Inhibition of miR-9 de-represses HuR and DICER1 and impairs Hodgkin lymphoma tumour outgrowth in vivo. Oncogene 31:5081-5089
18. Zheng L, Qi T, Yang D, Qi M, Li D, Xiang X, Huang K, Tong Q (2013) microRNA-9 suppresses the proliferation, invasion and metastasis of gastric cancer cells through targeting cyclin D1 and Ets1. PLoS One 8:e55719
19. Liu N, Sun Q, Chen J, Li J, Zeng Y, Zhai S, Li P, Wang B, Wang X (2012) microRNA-9 suppresses uveal melanoma cell migration and invasion through the NF-κB1 pathway. Oncol Rep 28:961-968
20. Guo R, Wu Q, Liu F, Wang Y (2011) Description of the CD133+ subpopulation of the human ovarian cancer cell line OVCAR3. Oncol Rep 25:141-146
21. Gao F, Zhao ZL, Zhao WT, Fan QR, Wang SC, Li J, Zhang YQ, Shi JW, Lin XL, Yang S, Xie RY, Liu W, Zhang TT, Sun YL, Xu K, Yao KT, Xiao D (2013) miR-9 modulates the expression of interferon-regulated genes and MHC class I molecules in human nasopharyngeal carcinoma cells. Biochem Biophys Res Commun 431:610-616
22. Malzkorn B, Wolter M, Liesenberg F, Grzendowski M, Stühler K, Meyer HE, Reifenberger G (2010) Identification and functional characterization of microRNAs involved in the malignant progression of gliomas. Brain Pathol 20:539-550
23. Kim TM, Huang W, Park R, Park PJ, Johnson MD (2011) A developmental taxonomy of glioblastoma defined and maintained by microRNAs. Cancer Res 71:3387-3399
24. Ben-Hamo R, Efroni S (2011) Gene expression and network-based analysis reveals a novel role for hsa-miR-9 and drug control over the p38 network in glioblastoma multiforme progression. Genome Med 3:77
25. Sun J, Gong X, Purow B, Zhao Z (2012) Uncovering microRNA and transcription factor mediated regulatory networks in glioblastoma. PLoS Comput Biol 8:e1002488
26. Zhou X, Marian C, Makambi KH, Kosti O, Kallakury BV, Loffredo CA, Zheng YL (2012) microRNA-9 as potential biomarker for breast cancer local recurrence and tumor estrogen receptor status. PLoS One 7:e39011